Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Dr. Jeremy Abramson is the Director of the Lymphoma Program and the Jon and Jo Ann Hagler Chair in Lymphoma at the Massachusetts General Hospital Cancer Center. Dr. Abramson is also an Assistant Professor of Medicine at Harvard Medical School. He earned his medical degree from the Mount Sinai School of Medicine and earned a Master's Degree in Medical Sciences from Harvard Medical School. Dr. Abramson served a residency in Internal Medicine at the Massachusetts General Hospital in Boston, and a fellowship in Hematology and Oncology at the Dana-Farber Cancer Institute. He is board certified in Medical Oncology and Hematology and his clinical and research interests are in lymphoid malignancies, including all non-Hodgkin lymphomas (both B-cell and T-cell lymphomas), as well as Hodgkin lymphoma (also called Hodgkin's disease), and chronic lymphocytic leukemia (CLL). Dr. Abramson is a member of the American Society of Hematology, the American Society of Clinical Oncology, and a Fellow of the American College of Physicians.